Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck-Reference-Cited by-同舟云学术

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck

Published:2010-02 Issue:2 Volume:21 Page:342-347
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Wirth L.J.,Allen A.M.,Posner M.R.,Haddad R.I.,Li Y.,Clark J.R.,Busse P.M.,Chan A.W.,Goguen L.A.,Norris C.M.,Annino D.J.,Tishler R.B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/2/342/931681/mdp477.pdf

Reference33 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Head and neck cancer;Argiris;Lancet,2008

3. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet,2000

4. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer;Brizel;N Engl J Med,1998

5. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer;Pharmaceutics;2024-09-11

2. Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells;Expert Opinion on Therapeutic Targets;2024-04-27

3. Research Progress on the Expression and Clinical Application of EGFR Gene in Head and Neck Squamous Cell Carcinoma;Advances in Clinical Medicine;2023

4. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma;European Journal of Medicinal Chemistry;2020-12

5. Chemotherapy and dysphagia: the good, the bad, the ugly;Current Opinion in Otolaryngology & Head & Neck Surgery;2020-10-06